from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3224/-

LFCtreatmentdescriptionclass of inhibitor

0.026

Amikacinug/mL Amikacintranslation

0.501

Cap5-10ug/mL Capreomycintranslation

0.317

Rox10-50 ug/mL Roxithromycintranslation

0.768

SM2-5 ug/mL Streptomycintranslation

-0.967

Tet5-10 ug/mL Tetracyclinetranslation

-1.005

Rif0.2-5ug/mL Rifampicintranscription

-1.515

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.407

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.055

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-1.291

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.760

Clofazimine10-13 ug/mL Clofaziminerespiration

0.219

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.340

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.347

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.660

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.187

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.640

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-2.152

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.322

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.541

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.770

KCN5-20 ug/mL Potassium cyaniderespiration

0.264

NaN30.2-2 mM Sodium aziderespiration

0.485

Nigericin50 uM Nigericinrespiration

-0.526

TRC10-150 ug/mL Triclosanrespiration

-1.670

TRZ10-25 ug/mL Thioridazinerespiration

-2.357

Valinomycin0.5-10 uM Valinomycinrespiration

0.451

ZnSO42 mM ZnSO4respiration

0.221

menadione6-10 ug/mL Menadionerespiration

-0.254

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.781

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.076

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.724

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.083

NRP_1Non-replicating persistence stage 1dosRassociated

0.698

Amp0.2mg/mL AmpicillincellWall

0.635

Cephalexin20-100 ug/mL CephalexincellWall

0.837

Cerulenin0.32-5 ug/mL CerulenincellWall

0.457

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.601

EMB10-20 ug/mL EthambutolcellWall

0.830

Eta12-40 ug/mL EthionamidecellWall

0.915

INH0.2-0.4 ug/mL IsoniazidcellWall

0.756

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.412

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.409

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.007

BZA0.12 mg/mL BenzamidearomaticAmides

0.222

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.005

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.203

H2O24 mM hydrogen peroxideDNAdamaging

-0.254

Levo10 ug/mL LevofloxacinDNAdamaging

1.041

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.709

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.353

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.155

UVUV-irradiationDNAdamaging

-1.018

ARP41-4 ug/mL Antitubercular compound ARP4?

0.761

Antimycin12.5-50 ug/mL Antimycin A?

0.424

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.815

PA_110-50 ug/mL Antitubercular compound PA-1?

0.895

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.729

PA8240.2-2 ug/mL PA-824?

-0.810

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.245

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.191

Verapamil50 uM Verapamil?

0.545

mercaptoethanol2 mM 2-Mercaptoethanol?

0.481

methoxatin10-20 ug/mL Methoxatin?